Uncover key drivers, emerging technologies, and competitive movements shaping the medical and diagnostic laboratory services market from 2026–2035 with trusted insights from The Business Research Company
Across 2026–2030, what is the expected market valuation path of the Medical And Diagnostic Laboratory Services Market?
The medical and diagnostic laboratory services market has experienced significant expansion recently. This sector is projected to increase from $212.41 billion in 2025 to $229.3 billion in 2026, achieving a compound annual growth rate (CAGR) of 8.0%. The growth observed in previous periods is attributable to elements such as a rising disease burden, increasing dependence of physicians on diagnostics, the development of hospital infrastructure, growing healthcare awareness, and improved availability of basic diagnostic testing.
The market for medical and diagnostic laboratory services is projected to experience substantial expansion over the upcoming years. By 2030, this market is anticipated to reach a valuation of $314.61 billion, demonstrating an 8.2% compound annual growth rate (CAGR). Key factors driving this growth during the forecast period include the escalating prevalence of chronic diseases, the growing need for personalized diagnostic solutions, the proliferation of preventive healthcare initiatives, the broadening of diagnostic services into tier 2 and tier 3 urban areas, and a rise in both public and private healthcare expenditures. Significant trends anticipated throughout the forecast period encompass an increasing inclination towards preventive and early disease detection diagnostics, a noticeable move towards outsourced diagnostic services, the development of integrated diagnostic imaging and laboratory networks, wider acceptance of home sample collection services, and an intensified emphasis on maintaining quality standards and adhering to accreditation requirements.
Access Your Free Sample Report for In-Depth Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=1965&type=smp
Which Drivers Are Supporting The Rise Of The Medical And Diagnostic Laboratory Services Market?
The projected increase in the elderly population is set to boost the expansion of the Medical And Diagnostic Laboratory Services Market. This demographic segment includes older adults, typically defined as individuals aged 65 or above. For seniors, medical and diagnostic laboratory services are essential for early detection and ongoing monitoring of diseases, facilitating timely interventions and improving overall health outcomes. For instance, in July 2024, the UK Parliament’s House of Commons Library, a UK-based government administration, reported that in 2022, 12.7 million individuals aged 65 or older resided in the UK, making up 19% of the total population. This figure is projected to rise to 22.1 million by 2072, encompassing 27% of the population. Hence, the increasing geriatric population is a key factor driving the growth of the Medical And Diagnostic Laboratory Services Market.
What Leading Segments Are Studied In The Medical And Diagnostic Laboratory Services Market?
The medical and diagnostic laboratory services market covered in this report is segmented –
1) By Type: Diagnostic Imaging Centers, Medical Laboratory Services
2) By Type of Expenditure: Public, Private
3) By Application: Cardiology, Oncology, Neurology, Orthopedics, Gastroenterology, Gynecology, Other Applications
4) By End User Gender: Male, Female
Subsegments:
1) By Diagnostic Imaging Centers: X-ray Imaging, Magnetic Resonance Imaging (MRI), Ultrasound Imaging, Computed Tomography (CT) Scans, Nuclear Imaging, Mammography
2) By Medical Laboratory Services: Clinical Chemistry, Hematology, Microbiology, Immunology/Serology, Molecular Diagnostics, Pathology, Blood Banking/Transfusion Services
Which Market Trends Are Opening Growth Opportunities In The Medical And Diagnostic Laboratory Services Market?
Leading companies in the medical and diagnostic laboratory services market are concentrating on developing advanced solutions, such as enterprise molecular-diagnostics workflow software. This effort aims to address the increasing need for quicker, higher-throughput qPCR testing, enhanced assay standardization, regulatory traceability, and improved lab efficiency, all driven by public-health surveillance and expanding molecular test menus. Enterprise molecular-diagnostics workflow software acts as a unified, on-premise or integrated platform, consolidating instruments, assays, sample and reagent tracking, automated quality control and data interpretation, and laboratory information systems (LIS) within a single interface. For example, in July 2023, Thermo Fisher Scientific, a US-based life-sciences company, introduced Diomni Enterprise Software, an enterprise platform for qPCR/molecular diagnostics workflows. Diomni is designed as a scalable, on-premise software suite that connects sample tracking, instrument control, and result reporting into a single ecosystem. It supports assay development files (ADF) and routine qPCR workflows, automates QC and fluorescence-curve interpretation, and integrates with LIS for audit trails and 21 CFR Part 11-style controls. Its distinctive features include customizable, lockable assay templates, concurrent multi-user access, automated reagent and sample traceability, and integrated compliance/audit functionality. These benefits result in fewer manual steps, improved reproducibility, and a reduction of up to multi-hour reductions in qPCR time-to-results, according to early adopters.
Which Leading Companies Dominate The Medical And Diagnostic Laboratory Services Market Share?
Major companies operating in the medical and diagnostic laboratory services market are Laboratory Corporation of America, Eurofins Scientific, Quest Diagnostics Incorporated, Sonic Healthcare Limited, RadNet, OPKO Health, Myriad Genetics, Charles River Laboratories Inc., NeoGenomics Laboratories Inc., Bio-Reference Laboratories Inc., Guardant Health Inc., Invitae Corporation, Natera Inc., Foundation Medicine Inc., Veracyte Inc., Exact Sciences Corporation, Fulgent Genetics Inc., Progenity Inc., Adaptive Biotechnologies Corporation, Biocept Inc., Interpace Biosciences Inc., Psychemedics Corporation, Aeon Global Health Corp., Avellino Labs USA Inc., Bio-Techne Corporation, Enzo Clinical Labs Inc., Genoptix Inc., Genova Diagnostics Inc.
Access The Complete Report For Deeper Market Insights:
Which Region Is Anticipated To See The Fastest Growth In The Medical And Diagnostic Laboratory Services Market?
North America was the largest region in the medical and diagnostic laboratory services market in 2025. Asia-Pacific was the second largest region in the medical and diagnostic laboratory services market. The regions covered in the medical and diagnostic laboratory services market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request Your Customized Medical And Diagnostic Laboratory Services Market Research Report for Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=1965&type=smp
Browse Through More Reports Similar to the Global Medical And Diagnostic Laboratory Services Market 2026, By The Business Research Company
Veterinary Laboratory Testing Services Market Report 2026
Medical And Diagnostic Laboratory Services Market Report 2026
Laboratory Testing Services Market Report 2026
https://www.thebusinessresearchcompany.com/report/laboratory-testing-services-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model